National Institutes of Health: Sarcoidosis trials

The registry lists 11 Sarcoidosis studies with National Institutes of Health as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 2 3No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Atorvastatin to Treat Pulmonary SarcoidosisCompletedNCT00279708Phase 2Results posted
• Uveitis/Intraocular Inflammatory Disease Biobank (iBank)CompletedNCT02656381
• Eye and Immunogenetic Features of SarcoidosisCompletedNCT00379275
• Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System DiseasesCompletedNCT00366509
• Salivary Proteins in Disease and HealthCompletedNCT00100204
• Sarcoid Genetic Analysis (SAGA)CompletedNCT00005542
• Genetic Epidemiology of SarcoidosisCompletedNCT00005531
• A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)CompletedNCT00005276
• Treatment of Pulmonary Sarcoidosis With PentoxifyllineCompletedNCT00001877Phase 2
• Study of Eye Tissue for SarcoidosisCompletedNCT00001278
• Diffuse Fibrotic Lung DiseaseCompletedNCT00000596Phase 2